Company / Capital Expenditures
Sigyn Therapeutics, Inc. Capital Expenditures History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$3.0K
FY2018
5-year range
$2.5K / $3.0K
FY2015-FY2018
Trend
+20.4%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2,950 in FY2018.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +6.4%, indicating consistent growth.
- In FY2018, capital expenditures increased 20.4% year-over-year.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | $3.0K | +20.4% |
| FY2015 | $2.5K | - |
As of FY2018 · SEC 10-K · Updated Jun 29, 2026